Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.74 USD | -6.50% | -7.58% | -44.08% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.08% | 404M | |
+3.27% | 108B | |
+10.99% | 104B | |
+1.28% | 22.33B | |
-12.81% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.37% | 17.64B | |
+3.83% | 14.05B | |
+35.57% | 12.51B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Morgan Stanley Adjusts Price Target on Talaris Therapeutics to $3 From $6, Keeps Equalweight Rating